NeuroPace (NPCE) Times Interest Earned (2020 - 2026)
NeuroPace's (NPCE) quarterly Times Interest Earned came in at -$0.33 in Q1 2026, up 85.97% year-on-year from -$0.18 in Q1 2025, and up 49.44% quarter-over-quarter from -$0.65 in Q4 2025.
NeuroPace (NPCE) Times Interest Earned (2020 - 2026) Analysis & Trends
NeuroPace's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.33 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 85.97% year-over-year to -$0.33 in Q1 2026; TTM through Mar 2026 was -$0.99, a 54.89% increase from a year earlier, with the FY2025 full-year figure at -$0.73, down 161.86% from the prior year.
- Times Interest Earned grew to -$0.33 in Q1 2026 per NPCE's latest filing, from -$0.65 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.33 in Q1 2026 and bottomed at -$5.93 in Q2 2022.
- The 5-year median for Times Interest Earned is -$2.72 (2023), against an average of -$2.88.
- Across the five-year window, Times Interest Earned plunged 154.6% in 2022 and surged 85.97% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$5.08 in 2022, then soared by 54.8% to -$2.3 in 2023, then advanced by 27.68% to -$1.66 in 2024, then soared by 60.9% to -$0.65 in 2025, then jumped by 49.44% to -$0.33 in 2026.
- Per Business Quant, the three latest NPCE Times Interest Earned figures stand at -$0.33 (Q1 2026), -$0.65 (Q4 2025), and -$0.85 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.65 |
| Sep 30, 2025 | -0.85 |
| Jun 30, 2025 | -0.43 |
| Mar 31, 2025 | -2.34 |
| Dec 31, 2024 | -1.66 |
| Sep 30, 2024 | -1.93 |
| Jun 30, 2024 | -2.83 |
| Mar 31, 2024 | -3.28 |
| Dec 31, 2023 | -2.30 |
| Sep 30, 2023 | -2.72 |
| Jun 30, 2023 | -3.70 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -5.08 |
| Sep 30, 2022 | -5.35 |
| Jun 30, 2022 | -5.93 |
| Mar 31, 2022 | -5.33 |
| Dec 31, 2021 | -3.38 |
| Sep 30, 2021 | -3.42 |
| Jun 30, 2021 | -2.46 |